Research on Fang Min and others showed that kaempferol could adjust TNF‐α, IL‐17, AGE‐RAGE, and other signal channels through critical targets such as AKT1 and TNF‐α to treat T2DM [57]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.